Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus

JAMA Dermatol. 2013 Sep;149(9):1077-81. doi: 10.1001/jamadermatol.2013.4745.

Abstract

Importance: Spitz nevi are benign melanocytic proliferations that can sometimes be clinically and histopathologically difficult to distinguish from melanoma. Agminated Spitz nevi have been reported to arise spontaneously, in association with an underlying nevus spilus, or after radiation or chemotherapy. However, to our knowledge, the genetic mechanism for this eruption has not been described.

Observations: We report a case of agminated Spitz nevi arising in a nevus spilus and use exome sequencing to identify a clonal activating point mutation in HRAS (GenBank 3265) (c.37G→C) in the Spitz nevi and underlying nevus spilus. We also identify a secondary copy number increase involving HRAS on chromosome 11p, which occurs during the development of the Spitz nevi.

Conclusions and relevance: Our results reveal an activating HRAS mutation in a nevus spilus that predisposes to the formation of Spitz nevi. In addition, we demonstrate a copy number increase in HRAS as a "second hit" during the formation of agminated Spitz nevi, which suggests that both multiple Spitz nevi and solitary Spitz nevi may arise through similar molecular pathways. In addition, we describe a unique investigative approach for the discovery of genetic alterations in Spitz nevi.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Humans
  • Male
  • Nevus, Epithelioid and Spindle Cell / genetics
  • Nevus, Epithelioid and Spindle Cell / pathology*
  • Nevus, Pigmented / genetics
  • Nevus, Pigmented / pathology*
  • Point Mutation
  • Proto-Oncogene Proteins p21(ras) / genetics*
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology*

Substances

  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)